Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Abbott Laboratories Community
NYSE:ABT Community
2
Narratives
written by author
0
Comments
on narratives written by author
211
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Abbott Laboratories
Popular
Undervalued
Overvalued
Abbott Laboratories
KR
Krishpaal
Community Contributor
Abbott Labs is set to increase its profit margin by 31.826% in the next 5 years
Tes
View narrative
US$129.28
FV
1.3% overvalued
intrinsic discount
7.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
29 days ago
author updated this narrative
Abbott Laboratories
AN
AnalystConsensusTarget
Consensus Narrative from 25 Analysts
Expanding Emerging Markets And Diagnostics Will Drive Prospects Despite Headwinds
Key Takeaways Strong demand from emerging markets and aging populations, along with new product launches, is expected to fuel sustained growth and diversify revenue streams. Innovation in high-margin medical technologies and a diversified business mix will drive market share gains and support stable, long-term earnings.
View narrative
US$142.48
FV
8.1% undervalued
intrinsic discount
7.34%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
115
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
ABT
ABT
Abbott Laboratories
Your Fair Value
US$
Current Price
US$130.93
3.4% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
60b
2015
2018
2021
2024
2025
2027
2030
Revenue US$60.2b
Earnings US$19.5b
Advanced
Set Fair Value